B.C. pharmaceutical company’s stocks double in value after successful lupus drug trial

More than 40 per cent of patients using voclosporin saw improvements in kidney function

Saanich-based pharmaceutical company, Aurinia Pharmaceuticals, saw share values soar on Thursday after success with clinical trials for a new lupus drug.

On Dec. 4, the company announced that results from the AURORA Phase 3 drug trials for voclosporin had been successful in treating kidney inflammation in patients with lupus nephritis – an autoimmune disease.

Aurinia’s chief medical officer Neil Solomons explained that patients with lupus can experience “irreversible kidney damage” that can lead to kidney failure and death.

READ ALSO: Saanich biotech company secures $52M US for global drug study

The study included 357 patients from around the world with lupus and the results showed that participants using voclosporin experienced a “renal response rate” of 40.8 per cent while just 22.5 per cent of participants in the control group – those who didn’t receive the drug – saw improvements.

Data also indicated that the group taking voclosporin saw no more adverse events than the group receiving standard lupus treatment, noted Brad Rovin, chief of the nephrology division at the Ohio State University Wexner Medical Centre.

Following the announcement of the drug’s successful Phase 3 trial, the company’s share price exploded on Thursday, rising from Wednesday’s close of $11.13 per share to touch a 52-week high of $23.04 before closing at $19.75. Its shares have risen from a 52-week low of $4.70 to close Friday at $20.48 – a gain of 336 per cent, driving the company’s market cap to $1.93 billion.

READ ALSO: Mental health call temporarily shuts down Trans Canada Highway in View Royal

Lupus has historically been difficult to treat and new treatment options were needed, said Stevan Gibson, president and CEO of the Lupus Foundation of America. Voclosporin is the first effective therapeutic treatment option and the successful trial marks a step forward in treating the potentially deadly disease, he noted.

Chief executive Peter Greenleaf noted that staff were “thrilled with the outcomes” of the trial and that the drug’s success is significant for people living with lupus – close to 3 million people worldwide. The company is planning to put the drug on the market as early as 2021, but first it must pass though the U.S. Food and Drug Administration (FDA) process. The drug was given a fast track by the FDA in 2016 and the company plans to submit to the FDA in early 2020.

With files from Paul Bucci.


@devonscarlett
Like us on Facebook and follow us on Twitter.

devon.bidal@saanichnews.com

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Five pot shops put applications forward to Mission Council

Three dispensaries are vying for one block on 1st Avenue

Camo-clad man carrying guns arrested in Chilliwack

Turns out the guns were trigger locked and the man was subsequently released by RCMP

Drive-by celebration for Mission couple’s 65th anniversary, 90th birthday

Don and Clara Coubrough watched as family members drove by to say congratulations

LETTER: Mission tax increase should be trimmed

Any increase above the rate of inflation is unsustainable

Man from Mexico reported missing in Abbotsford

Antonio Fernandez, 29, was last seen on Monday, May 25

B.C. retirement home creates innovative ‘meet-up’ unit for elderly to see family face-to-face

Innovative ‘purpose-built’ unit keeps residents safe when seeing family for first time since COVID-19

Facing changes together: Your community, your journalists

The importance of accurate, ethical reporting is critical – perhaps as never before

COVID-19: B.C. too dependent on foreign food production workers

New B.C. job site links unemployed with farm, seafood work

Aldergrove drive-in theatre to reopen at 50-vehicle capacity, gets green light on concession

100 cars of people will now watch films, hoping to adhere to new provincial health 50-car capacity

New oversight for COVID-19 outbreak at Langley Lodge

Fraser Health is also sending in a germ-killing machine to fight the virus

B.C. businesses ‘can’t shoulder burden’ of COVID-19 sick pay

Trudeau’s plan should be tied to federal emergency aid

Police stop Lower Mainland men with parachutes from jumping off Okanagan bridge

The men had parachutes in their backpacks, and indicated they were going to jump off a bridge

Another Asian giant ‘murder hornet’ found in Lower Mainland

This is the farthest east the invasive species has been found so far

B.C. girl left temporarily paralyzed by tick bite sparks warning from family

Mom says parents need to check their kids when they go camping

Most Read